Navigation Links
Pitt team finds 'Achilles Heel' of key HIV replication protein
Date:1/24/2013

PITTSBURGH, Jan. 24, 2013 Researchers at the University of Pittsburgh School of Medicine may have found an "Achilles heel" in a key HIV protein. In findings published online today in Chemistry and Biology, they showed that targeting this vulnerable spot could stop the virus from replicating, potentially thwarting HIV infection from progressing to full-blown AIDS.

Previous research demonstrated that a small HIV protein called Nef interacts with many other proteins in infected cells to help the virus multiply and hide from the immune system. The Pitt group developed a way to track Nef activity in high-throughput drug screening protocols by linking it to an enzyme called Hck, which is activated by Nef in HIV-infected cells, explained senior author Thomas E. Smithgall, Ph.D., William S. McEllroy Professor and Chair, Department of Microbiology and Molecular Genetics.

"We reasoned that agents that prevent Nef from its usual interactions with other proteins might be able to stop HIV from replicating and infecting other cells," Dr. Smithgall said. "For this study, we devised an automated screening procedure and tested nearly 250,000 compounds to find ones that could block Nef activity."

One of the compounds they discovered, called B9, seemed particularly potent at blocking Nef. In follow-up experiments, the research team examined how B9 accomplished this and found that it could prevent two Nef molecules from interacting to form dimers as effectively as a mutation in a critical area of the protein surface. The inability of Nef to dimerize consequently impairs its function in the viral replication process.

"This pocket where B9 binds to Nef and where Nef forms a dimer indicates it's a hot spot, or Achilles heel, that could represent a new target for HIV drugs," Dr. Smithgall said. "Our test tube and cell culture experiments show that blocking this site brings HIV replication to a halt."

The team is working with medicinal chemists at the University of Pittsburgh Drug Discovery Institute (DDI) to find analogs of B9 that have therapeutic potential, and plan to assess them in animal models of HIV/AIDS.


'/>"/>
Contact: Anita Srikameswaran
SrikamAV@upmc.edu
412-578-9193
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Related biology news :

1. Plants adapt to drought but limits are looming, study finds
2. Study finds linchpin of skin response to UVA light
3. Privacy a problem for mothers of newborns in neonatal intensive care units, CWRU study finds
4. Study finds a new culprit for epileptic seizures
5. Born to lead? Leadership can be an inherited trait, study finds
6. Team finds gene that promotes drug resistance in cancer
7. Study finds Jurassic ecosystems were similar to modern: Animals flourish among lush plants
8. Major cuts to surging CO2 emissions are needed now, not down the road, study finds
9. Bering Sea study finds prey density more important to predators than biomass
10. Hebrew University study finds key mechanism in calcium regulation
11. Black piranha, megapiranha have most powerful bites of fish living or extinct, finds GW researcher
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 21, 2017 Optimove ... used by retailers such as 1-800-Flowers and AdoreMe, ... — Product Recommendations and Replenishment. Using Optimove,s machine learning ... personalized product and replenishment recommendations to their customers ... on predictions of customer intent drawn from a ...
(Date:3/13/2017)... Future of security: Biometric Face Matching software  Continue ... ... to match face pictures against each other or against large databases. The recognition ... ... software for biometric Face Matching on the market. The speed is at 100 ...
(Date:3/6/2017)... MATEO, Calif. , March 6, 2017 /PRNewswire/ ... marketing and sales technology, today announced Predictive Sales ... solution for infusing actionable sales intelligence into Salesforce. ... to automatically enable their sales organizations with deep ... messages that allow for intelligent engagement. Predictive Sales ...
Breaking Biology News(10 mins):
(Date:3/30/2017)... In today,s pre-market research, Stock-Callers.com ... Corp. (NYSE: XON), Progenics Pharmaceuticals Inc. (NASDAQ: PGNX), and ... an article on Barron,s, Credit Suisse upgraded its rating on ... 21 st , 2017. These stocks research reports can be ... ...
(Date:3/29/2017)... Texas, March 29, 2017  Vermillion, Inc. (NASDAQ: ... disease, reported on its results for the fourth ... "2016 marked a pivotal year for ... guideline inclusion, international distribution agreements, major reimbursement progress ... network payer agreements. In addition we cleared our ...
(Date:3/29/2017)... N.J. and PETACH TIKVAH, ...  BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), ... technologies for neurodegenerative diseases, announced financial results ... "2016 was a highly successful ... important achievements and significant progress made on ...
(Date:3/29/2017)... ... March 29, 2017 , ... On the heels of the globally recognized ... Travel has announced that it will manage travel services for its 500th clinical trial ... the United States and Europe to offer travel management services specifically for clinical trials ...
Breaking Biology Technology: